Literature DB >> 33574048

Phosphoproteomic Analysis as an Approach for Understanding Molecular Mechanisms of cAMP-Dependent Actions.

Joseph A Beavo1, Martin Golkowski2, Masami Shimizu-Albergine2, Michael-Claude Beltejar2, Karin E Bornfeldt2, Shao-En Ong2.   

Abstract

In recent years, highly sensitive mass spectrometry-based phosphoproteomic analysis is beginning to be applied to identification of protein kinase substrates altered downstream of increased cAMP. Such studies identify a very large number of phosphorylation sites regulated in response to increased cAMP. Therefore, we now are tasked with the challenge of determining how many of these altered phosphorylation sites are relevant to regulation of function in the cell. This minireview describes the use of phosphoproteomic analysis to monitor the effects of cyclic nucleotide phosphodiesterase (PDE) inhibitors on cAMP-dependent phosphorylation events. More specifically, it describes two examples of this approach carried out in the authors' laboratories using the selective PDE inhibitor approach. After a short discussion of several likely conclusions suggested by these analyses of cAMP function in steroid hormone-producing cells and also in T-cells, it expands into a discussion about some newer and more speculative interpretations of the data. These include the idea that multiple phosphorylation sites and not a single rate-limiting step likely regulate these and, by analogy, many other cAMP-dependent pathways. In addition, the idea that meaningful regulation requires a high stoichiometry of phosphorylation to be important is discussed and suggested to be untrue in many instances. These new interpretations have important implications for drug design, especially for targeting pathway agonists. SIGNIFICANCE STATEMENT: Phosphoproteomic analyses identify thousands of altered phosphorylation sites upon drug treatment, providing many possible regulatory targets but also highlighting questions about which phosphosites are functionally important. These data imply that multistep processes are regulated by phosphorylation at not one but rather many sites. Most previous studies assumed a single step or very few rate-limiting steps were changed by phosphorylation. This concept should be changed. Previous interpretations also assumed substoichiometric phosphorylation was not of regulatory importance. This assumption also should be changed.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33574048      PMCID: PMC8058506          DOI: 10.1124/molpharm.120.000197

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.054


  71 in total

Review 1.  Regulation of cholesterol supply for mineralocorticoid biosynthesis.

Authors:  Alessandro M Capponi
Journal:  Trends Endocrinol Metab       Date:  2002-04       Impact factor: 12.015

2.  Interrogating cAMP-dependent kinase signaling in Jurkat T cells via a protein kinase A targeted immune-precipitation phosphoproteomics approach.

Authors:  Piero Giansanti; Matthew P Stokes; Jeffrey C Silva; Arjen Scholten; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

3.  Dual phosphorylation of protein phosphatase PPM1H promotes dephosphorylation of Smad1 in cellulo.

Authors:  Jin Osawa; Kazutoshi Akizuki; Akari Kashimura; Saki Ueta; Misato Nakatani; Yuiko Inui; Yasushi Shigeri; Atsuhiko Ishida; Isamu Kameshita; Noriyuki Sueyoshi
Journal:  Biochem Biophys Res Commun       Date:  2020-06-26       Impact factor: 3.575

Review 4.  Multiple Roles of Rab GTPases at the Golgi.

Authors:  Cinzia Progida
Journal:  Results Probl Cell Differ       Date:  2019

Review 5.  Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?

Authors:  Claire Lugnier; Alain Meyer; Samy Talha; Bernard Geny
Journal:  Pharmacol Ther       Date:  2020-01-09       Impact factor: 12.310

Review 6.  Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences.

Authors:  P R Manna; D M Stocco
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-03

Review 7.  The biogenesis of lipid droplets: Lipids take center stage.

Authors:  Mingming Gao; Xun Huang; Bao-Liang Song; Hongyuan Yang
Journal:  Prog Lipid Res       Date:  2019-07-24       Impact factor: 16.195

Review 8.  Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets.

Authors:  Stephanie Makhoul; Elena Walter; Oliver Pagel; Ulrich Walter; Albert Sickmann; Stepan Gambaryan; Albert Smolenski; René P Zahedi; Kerstin Jurk
Journal:  Nitric Oxide       Date:  2018-03-14       Impact factor: 4.427

9.  Axelrod Symposium 2019: Phosphoproteomic Analysis of G-Protein-Coupled Pathways.

Authors:  Katharina Schleicher; Manuela Zaccolo
Journal:  Mol Pharmacol       Date:  2020-02-28       Impact factor: 4.436

10.  PKA-independent vasopressin signaling in renal collecting duct.

Authors:  Arnab Datta; Chin-Rang Yang; Kavee Limbutara; Chung-Lin Chou; Markus M Rinschen; Viswanathan Raghuram; Mark A Knepper
Journal:  FASEB J       Date:  2020-03-26       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.